Last updated: September 5, 2021
Sponsor: Chinese Academy of Medical Sciences
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mesothelioma
Cancer
Treatment
N/AClinical Study ID
NCT05042557
NCC202062402
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Pathologically confirmed as malignant pleural mesothelioma
- Aged over 18
Exclusion
Exclusion Criteria:
- Follow-up less than 3 months
Study Design
Total Participants: 500
Study Start date:
June 01, 2021
Estimated Completion Date:
December 20, 2022
Connect with a study center
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, 100021
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.